Thank you, Mr. Chair, and thank you all for coming. This has all been very informative. I agree with our chair that we've been doing this for a very long time and we're still getting new information.
Mr. Blomqvist, there was something in a statement you made that I wanted to put a wrinkle in. You said that under a large universal plan, there would not be a lot of control over doctors' prescribing practices, but Madame Forcier actually just made a reference to something in that connection.
If you had an evidence-based formulary of drugs that were covered by the plan that stipulated the drugs you could prescribe, would that not apply that measure of control that was needed on prescribing practices?